Trial Profile
A Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort Respules in Patient Aged 5-Year Old or Younger in Outpatient Department.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Apr 2013
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms PUL-NIS
- Sponsors AstraZeneca
- 29 May 2009 Actual patient number (914) added as reported by ClinicalTrials.gov.
- 15 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Feb 2009 Status changed from recruiting to active, no longer recruiting, based on information from ClinicalTrials.gov.